JPMorgan Chase & Co. Acquires 102,660 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

JPMorgan Chase & Co. grew its holdings in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 57.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 280,453 shares of the company's stock after acquiring an additional 102,660 shares during the quarter. JPMorgan Chase & Co. owned 0.67% of SI-BONE worth $3,932,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of SIBN. American Century Companies Inc. raised its holdings in SI-BONE by 11.0% in the 4th quarter. American Century Companies Inc. now owns 2,378,068 shares of the company's stock valued at $33,341,000 after acquiring an additional 236,167 shares in the last quarter. State Street Corp raised its stake in shares of SI-BONE by 5.1% in the third quarter. State Street Corp now owns 1,081,871 shares of the company's stock valued at $15,125,000 after purchasing an additional 52,972 shares in the last quarter. Geode Capital Management LLC lifted its position in SI-BONE by 3.4% in the third quarter. Geode Capital Management LLC now owns 924,044 shares of the company's stock worth $12,921,000 after purchasing an additional 30,005 shares during the period. Harbor Capital Advisors Inc. boosted its stake in SI-BONE by 35.5% during the fourth quarter. Harbor Capital Advisors Inc. now owns 841,045 shares of the company's stock worth $11,791,000 after buying an additional 220,555 shares in the last quarter. Finally, Impax Asset Management Group plc increased its holdings in SI-BONE by 1.1% in the 4th quarter. Impax Asset Management Group plc now owns 766,761 shares of the company's stock valued at $10,750,000 after buying an additional 8,240 shares during the period. 98.11% of the stock is owned by institutional investors.

SI-BONE Price Performance

Shares of SI-BONE stock traded down $0.11 during mid-day trading on Friday, reaching $14.28. 36,925 shares of the stock were exchanged, compared to its average volume of 359,711. The company has a market cap of $606.23 million, a price-to-earnings ratio of -15.55 and a beta of 1.02. SI-BONE, Inc. has a fifty-two week low of $11.70 and a fifty-two week high of $19.16. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. The firm has a 50-day simple moving average of $15.07 and a 200 day simple moving average of $14.62.

SI-BONE (NASDAQ:SIBN - Get Free Report) last posted its earnings results on Monday, February 24th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.05. The company had revenue of $49.00 million during the quarter, compared to analysts' expectations of $48.87 million. SI-BONE had a negative net margin of 23.82% and a negative return on equity of 22.51%. On average, sell-side analysts predict that SI-BONE, Inc. will post -0.78 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Needham & Company LLC raised their price objective on shares of SI-BONE from $20.00 to $24.00 and gave the stock a "buy" rating in a report on Tuesday, February 25th. Cantor Fitzgerald restated an "overweight" rating and set a $25.00 price target on shares of SI-BONE in a research note on Tuesday, February 25th. Finally, Truist Financial reaffirmed a "buy" rating and set a $22.00 price objective (up from $18.00) on shares of SI-BONE in a report on Tuesday, February 25th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, SI-BONE has a consensus rating of "Buy" and a consensus target price of $24.40.

Insider Transactions at SI-BONE

In other SI-BONE news, insider Anthony J. Recupero sold 3,311 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $14.15, for a total value of $46,850.65. Following the transaction, the insider now directly owns 284,555 shares in the company, valued at approximately $4,026,453.25. This trade represents a 1.15 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Michael A. Pisetsky sold 3,128 shares of the business's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $14.14, for a total value of $44,229.92. Following the sale, the senior vice president now owns 244,878 shares of the company's stock, valued at approximately $3,462,574.92. The trade was a 1.26 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,776 shares of company stock worth $96,644. Insiders own 3.90% of the company's stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.